21 May 2009
The influence of chronic heart failure on pulmonary function tests in patients undergoing orthotopic heart transplantation
M Lizak, M Zakliczyński, A Jarosz, M ZembalaAnn Transplant 2009; 14(1): 66-67 :: ID: 880443
Abstract
Background: Chronic heart failure and airway's obstruction have overlapping syndromes. World criteria for diagnosing and grading of airway's obstruction are based on spirometry results, but may be inadequate when cardiac failure coexists. Cardiac component of pulmonary function tests' (PFT) results can be measured in patients undergoing orthotopic heart transplantation (OHT).
Material/Methods: In 29 patients PFT were performed according to the Polish Phtisiopulmonology Society guidelines before and one year after OHT in the years 2006-2008. Willcoxon matched pairs' tests were used for analysis in Statistica 7.1. General group characteristics included age, sex, NYHA, CCS, BMI, present medication, blood tests and chemistry, exercise test, right heart catheterisation and echocardiography results.
Results: One year after OHT significant improvement in forced expiratory volume in the first second (FEV1) and its percent of predicted value (FEV1%), forced vital capacity (FVC), FVC%, vital capacity (VC) and VC% was observed (accordingly: 2.56 vs. 2.96l, 82 vs. 93%, 3.30 vs. 3.81l, 85 vs. 97%, 3.38 vs. 4.04l, 85 vs. 100%, p<0.01). FEV1 and FVC increment exceeded the cut-off point of 12% of normal value (accordingly: 0.38 and 0.47l) established as spirometry criterion for obstruction reversibility. Elimination of the heart failure by OHT did not result in signifi cant changes in FEV1 to FVC ratio (FEV1%FVC) used as main diagnostic criterion of chronic obstructive lung disease.
Conclusions: Chronic heart failure contributes to FEV1 variability of 0.4l or 12.6% of normal value which limits the usefulness of PFT in diagnosing and grading of airway obstruction in this group. Induction of inhaled betamimetics and steroids should be carefully considered and symptom-based in this group of patients since optimalisation of CHF treatment can be the best way to improve spirometry results. FEV1%FVC seems independent of concomitant heart function impairment.
Keywords: Heart Transplantation, clinical outcome
In Press
Case report
Tongue Carcinoma in Immunosuppressed Patients After Liver and Kidney Transplantation: A Case SeriesAnn Transplant In Press; DOI: 10.12659/AOT.951715
Original article
Prevalence and Risk Factors of Hepatic Steatosis in Kidney Transplant RecipientsAnn Transplant In Press; DOI: 10.12659/AOT.952251
Original article
The Anatomical Landscape of Living Donor Livers: A 101-Case Retrospective Single-Center Study in Indonesia ...Ann Transplant In Press; DOI: 10.12659/AOT.952031
Original article
Decreased Ventilation Duration and ICU Stay Associated With Early Percutaneous Dilatational Tracheostomy Af...Ann Transplant In Press; DOI: 10.12659/AOT.953143
Most Viewed Current Articles
24 Aug 2021 : Review article 20,545
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 16,641
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
05 Apr 2022 : Original article 15,898
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 15,796
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988






